New Opioid Receptor Modulators and Agonists
Relevance for Pain and Opioid Use Disorder Management
Published on 28. September 2025
300 pages
978-0-443-26505-1 (ISBN)
Description
New Opioid Receptor Modulators and Agonists: Relevance for Pain and Opioid Use Disorder Management provides crucial insights for developing ideal synthetic opioids. It discusses opioid receptor modulators' structures and mechanisms, and their potential applications in treating pain, misuse, and addiction. This comprehensive resource delves into current research and therapeutic development avenues regarding opioid receptors' structure and function. Sections cover the rationale for developing allosteric modulators, identifying allosteric sites on opioid receptors, and the modulators' modes of action. Readers will gain a thorough understanding of creating ideal synthetic opioids and potential future research.It also explores pharmacogenomics, precision medicine, and various syndromes and comorbidities linked to opioid use. Lastly, it reviews novel synthetic opioids and the risks of misuse and overdose.
- Provides an in-depth look at opioid receptor system and novel aspects of opioid pharmacology<
- Discusses novel synthetic opioid clinical considerations
- Examines synthetic opioid misuse and pain management
More details
Other editions
Additional editions
Alan David Kaye | Scott Edwards
New Opioid Receptor Modulators and Agonists
Relevance for Pain and Opioid Use Disorder Management
Book
09/2025
Academic Press
€152.50
Shipment within 15-20 days
Content
The Opioid Receptor System and Novel Aspects of Opioid Pharmacology1. Making Sense of the Complexities of Opioid Receptor Function: Evolving Appreciation of Opioid Receptor Classification and Basic Characteristics2. Allostery at Opioid Receptors: Modulation with Small Molecule Ligands, Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management3. Opioid Agonist and Antagonist Pharmacology: Phenylpiperidines, Tramadol, Buprenoprhine, Methadone, and Codeine Derivatives Synthetic Opioid Clinical Considerations4. Pharmacogenomics/Precision Medicine: Opioid-related Interactions and Metabolism Considerations5. Opioid-associated Syndromes and Comorbidities6. Opioid-induced Hyperalgesia7. Drug Facts: Novel Synthetic Opioids Synthetic Opioid Misuse and Pain Management8. Roots of the Opioid Crisis: Description of the Four Waves of the Opioid Epidemic9. Opioids and Risk of Dependency: Neurobiology of Opioid Use Disorder10. Opioids and Risk of Dependency: Responsibilities of Healthcare Workers, Manufacturers, and Pharmacists11. CDC Guidelines for Chronic Pain in the Adult, Including Newer Guidelines Against Co-prescription with Benzodiazepines.12. Commonly Prescribed Opioids and Adjuvants in Acute and Chronic Pain Management13. Clinical Considerations of Commonly Prescribed Medications in Substance Abuse Management (e.g., buprenorphine (how is it prescribed); methadone (concerns over prolonged QT EKG prior to administration; urine drug screens14. The Role of Naltrexone and Novel Preparations for Substance Abuse and Pain Management15. Palliative Care for Cancer and Considerations for Opioid-mediated Suppression of Natural Killer Cells16. Abuse Deterrent Formulations of Opioids and Opioid Vaccines17. Opioid Detoxification Techniques
